These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15775792

  • 1. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.
    J Hypertens; 2005 Apr; 23(4):861-5. PubMed ID: 15775792
    [Abstract] [Full Text] [Related]

  • 2. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 3. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
    Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G.
    J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M, Mifune M, Kubota E, Itoh H, Saito I.
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [Abstract] [Full Text] [Related]

  • 6. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
    Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, Araki SI, Sugiomoto T, Koya D, Haneda M, Kashiwagi A.
    Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
    [Abstract] [Full Text] [Related]

  • 7. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Aug; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 8. Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension.
    Ishimitsu T, Yagi S, Ebihara A, Doi Y, Domae A, Shibata A, Kimura M, Sugishita Y, Sagara E, Sakamaki T, Murata K.
    Jpn Heart J; 1997 Nov; 38(6):831-40. PubMed ID: 9486936
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension.
    Ballew JR, Fink GD.
    J Hypertens; 2001 Sep; 19(9):1601-6. PubMed ID: 11564980
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
    Horita Y, Taura K, Taguchi T, Furusu A, Kohno S.
    Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H.
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.
    Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, Yoshida A, Kimura G.
    Kidney Int; 2004 Feb; 65(2):621-5. PubMed ID: 14717933
    [Abstract] [Full Text] [Related]

  • 13. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension.
    Uzu T, Kimura G.
    Circulation; 1999 Oct 12; 100(15):1635-8. PubMed ID: 10517735
    [Abstract] [Full Text] [Related]

  • 14. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
    Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S.
    Circ J; 2017 Jun 23; 81(7):948-957. PubMed ID: 28321001
    [Abstract] [Full Text] [Related]

  • 15. Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension.
    Shionoiri H, Kosaka T, Kita E, Takizawa T, Takasaki I.
    Hypertens Res; 2000 Nov 23; 23(6):593-600. PubMed ID: 11131271
    [Abstract] [Full Text] [Related]

  • 16. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N, Kalaitzidis R, Bakris GL.
    Am J Nephrol; 2009 Nov 23; 30(5):418-24. PubMed ID: 19738369
    [Abstract] [Full Text] [Related]

  • 17. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.
    Hypertension; 2007 Feb 23; 49(2):276-84. PubMed ID: 17159081
    [Abstract] [Full Text] [Related]

  • 18. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul 23; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 19. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Jul 23; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 20. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul 23; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.